Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes

被引:120
作者
Wollert, KC
Fiedler, B
Gambaryan, S
Smolenski, A
Heineke, J
Butt, E
Trautwein, C
Lohmann, SM
Drexler, H
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol & Hepatol, Hannover, Germany
[3] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany
关键词
nitric oxide; cyclic GMP; protein kinases; hypertrophy; apoptosis;
D O I
10.1161/hy1201.097292
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes with the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) (250 mumol/L) or the PKG-selective cGMP analog 8-pCPT-cGMP (500 mumol/L) activated endogenous PKG type I, as shown by the site-specific phosphorylation of vasodilator-stimulated phosphoprotein, a well-characterized PKG substrate. SNAP (250 mumol/L) and 8-pCPT-cGMP (500 mumol/L) modestly attenuated the hypertrophic response to alpha(1)-adrenergic stimulation with phenylephrine. Although a high concentration of SNAP (1000 mumol/L) promoted apoptosis in cardiomyocytes, as evidenced by the formation of histone-associated DNA fragments, antihypertrophic concentrations of SNAP (250 mumol/L) and 8-pCPT-cGMP (500 mumol/L) did not promote cell death. Because chronic activation downregulated endogenous PKG I, we explored whether gene transfer of PKG I would enhance the sensitivity of cardiomyocytes to the antihypertrophic effects of NO/cGMP. Indeed, after adenoviral overexpression of PKG Ibeta, SNAP (250 mumol/L) and 8-pCPT-cGMP (500 mumol/L) completely suppressed the hypertrophic response to alpha(1)-adrenergic stimulation. As observed in noninfected cells, SNAP (250 mumol/L) and 8-pCPT-cGMP (500 mumol/L) did not promote apoptosis in cardiomyocytes overexpressing PKG Ibeta. Moreover, overexpression of PKG Ibeta did not enhance the proapoptotic effects of 1000 mumol/L SNAP, implying PKG-independent effects of NO on apoptosis. Endogenous PKG I mediates antihypertrophic but not proapoptotic effects of NO in a cell culture model of cardiomyocyte hypertrophy. Adenoviral gene transfer of PKG I selectively enhances the antihypertrophic effects of NO without increasing the susceptibility to apoptosis.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 37 条
[1]   Cytokine-mediated apoptosis in cardiac myocytes - The role of inducible nitric oxide synthase induction and peroxynitrite generation [J].
Arstall, MA ;
Sawyer, DB ;
Fukazawa, R ;
Kelly, RA .
CIRCULATION RESEARCH, 1999, 85 (09) :829-840
[2]   The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation [J].
Bachmann, C ;
Fischer, L ;
Walter, U ;
Reinhard, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23549-23557
[3]   Parsing the effects of nitric oxide, S-nitrosothiols, and peroxynitrite on inducible nitric oxide synthase-dependent cardiac myocyte apoptosis [J].
Beckman, JS .
CIRCULATION RESEARCH, 1999, 85 (09) :870-871
[4]   The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes [J].
Bialik, S ;
Cryns, VL ;
Drincic, A ;
Miyata, S ;
Wollowick, AL ;
Srinivasan, A ;
Kitsis, RN .
CIRCULATION RESEARCH, 1999, 85 (05) :403-414
[5]   ANALYSIS OF THE FUNCTIONAL-ROLE OF CGMP-DEPENDENT PROTEIN-KINASE IN INTACT HUMAN PLATELETS USING A SPECIFIC ACTIVATOR 8-PARA-CHLOROPHENYLTHIO-CGMP [J].
BUTT, E ;
NOLTE, C ;
SCHULZ, S ;
BELTMAN, J ;
BEAVO, JA ;
JASTORFF, B ;
WALTER, U .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) :2591-2600
[6]   Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts [J].
Calderone, A ;
Thaik, CM ;
Takahashi, N ;
Chang, DLF ;
Colucci, WS .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :812-818
[7]   Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice [J].
Hauser, W ;
Knobeloch, KP ;
Eigenthaler, M ;
Gambaryan, S ;
Krenn, V ;
Geiger, J ;
Glazova, M ;
Rohde, E ;
Horak, I ;
Walter, U ;
Zimmer, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :8120-8125
[8]  
Ing DJ, 1999, CIRC RES, V84, P21
[9]  
Ishigai Yutaka, 1997, American Journal of Physiology, V273, pH2659
[10]   A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy [J].
Kishimoto, I ;
Rossi, K ;
Garbers, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2703-2706